MRNA · Moderna, Inc.
$63.32
-0.33 (-0.52%)
At close · Aug 14
Market Cap
$25.28B
Shares
399.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-31 | 2026-06-30 | |
| 8-K | 2026-07-31 | — | |
| 8-K | 2026-07-08 | 2026-07-06 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 8-K | 2026-05-11 | 2026-05-06 | |
| 8-K | 2026-05-01 | — | |
| 10-Q | 2026-05-01 | 2026-03-31 | |
| DEF 14A | 2026-03-16 | 2026-05-06 | |
| 8-K | 2026-03-05 | 2026-03-03 | |
| 10-K | 2026-02-20 | 2025-12-31 | |
| 8-K | 2026-02-13 | — | |
| 8-K | 2026-02-11 | 2026-02-03 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-11-24 | 2025-11-19 | |
| 8-K | 2025-11-20 | — | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| DEF 14A | 2025-10-15 | 2025-11-12 | |
| 10-Q | 2025-08-01 | 2025-06-30 | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-05-05 | 2025-04-30 | |
| 8-K | 2025-05-01 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| DEF 14A | 2025-03-11 | 2025-04-30 | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-02 | 2024-09-28 | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-07-23 | 2024-07-19 | |
| 8-K | 2024-05-09 | 2024-05-06 | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-05-02 | — | |
| DEF 14A | 2024-03-21 | 2024-05-06 | |
| 10-K | 2024-02-23 | 2023-12-31 | |
| 8-K | 2024-02-22 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-12 | 2023-12-08 | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-10-16 | — | |
| 8-K | 2023-09-11 | — | |
| 8-K | 2023-08-03 | — |
Showing 1–50 of 136 filings
Key facts
CIK
1682852
CUSIP
60770K107
13F (30d)
727 filings
689 filers
Visit website
Investor relations